HTGM Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (14 Jun 2023 @ 16:00):

Stats
Today's Volume	725 429
Average Volume	253 915
Market Cap	1.06M
EPS	$0 ( 2024-05-08 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0281
ATR14	$0.314 (65.42%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-08	Barat Stephen	Sell	888	Common Stock
2023-03-31	Barat Stephen	Sell	52	Common Stock
2023-02-02	Barat Stephen	Sell	0	Common Stock
2023-02-02	Barat Stephen	Sell	4 166	Stock Option (right to buy)
2023-02-02	Barat Stephen	Sell	2 083	Stock Option (right to buy)

INSIDER POWER
92.41
Last 98 transactions
Buy: 3 245 171 \| Sell: 16 674

Volume Correlation

Long: 0.10 (neutral)

Short: -0.53 (weak negative)

Signal:(18.674) Neutral

HTG Molecular Diagnostics Correlation

10 Most Positive Correlations
CYXT	0.801

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

HTG Molecular Diagnostics Correlation - Currency/Commodity

-0.72
( moderate negative )

0.59
( weak )

-0.70
( moderate negative )

0.44
( neutral )

HTG Molecular Diagnostics Financials

Annual	2022
Revenue:	$6.37M
Gross Profit:	$1.79M (28.18 %)
EPS:	$-24.28

FY	2022
Revenue:	$6.37M
Gross Profit:	$1.79M (28.18 %)
EPS:	$-24.28

FY	2021
Revenue:	$8.91M
Gross Profit:	$716 868 (8.05 %)
EPS:	$-0.206

FY	2020
Revenue:	$8.55M
Gross Profit:	$4.56M (53.31 %)
EPS:	$-0.376

Financial Reports:

No articles found.

HTG Molecular Diagnostics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

HTG Molecular Diagnostics

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.